Exane Derivatives’s GRAVITY GRVY Stock Holding History

Exane Derivatives’s Portfolio GRVY Stock Details GRVY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$408	Hold	8	–	–	﹤0.01%	595
2022 Q1	$405	Hold	8	–	–	﹤0.01%	892
2021 Q4	$545	Hold	8	–	–	﹤0.01%	764
2021 Q3	$724	Sell	8 -72	-90%	-$7.02K	﹤0.01%	900
2021 Q2	$8.43K	Hold	80	–	–	﹤0.01%	751
2021 Q1	$9.2K	Buy	+80	New	+$12.4K	﹤0.01%	599

Other funds holding GRVY

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Ronit Capital London, United Kingdom $74.3M AUM 13.35% 1-Year Est. Return

SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return

HSBC Holdings London, United Kingdom $239B AUM 42.32% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

ACA

Apis Capital Advisors New York $1.03B AUM 383.18% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 57.61% 1-Year Est. Return

Exane Derivatives's GRVY Position: Q2 2022 in Review

Exane Derivatives held its GRAVITY (GRVY) position steady in Q2 2022 at 8 shares worth $408. The position accounts for ﹤0.01% of the portfolio, ranked #595.

Exane Derivatives first reported a position in GRVY in Q1 2021 and has held it in 6 quarters since. The position peaked at $9.2K in Q1 2021. 33 funds tracked by Wall St. Rank hold GRVY as of Q2 2022.

Exane Derivatives held 8 shares of GRAVITY worth $408 as of Q2 2022.
Exane Derivatives left its GRAVITY share count unchanged in Q2 2022.
GRAVITY made up ﹤0.01% of Exane Derivatives's portfolio in Q2 2022, its #595 holding.
Exane Derivatives first reported a position in GRAVITY in Q1 2021 and has held it in 6 quarters since.
Exane Derivatives's GRAVITY position peaked at $9.2K in Q1 2021.
33 funds tracked by Wall St. Rank held GRAVITY as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.